Patents by Inventor Hubert Penamberger

Hubert Penamberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
    Patent number: 7166694
    Abstract: The present invention provides a method for producing a vaccine against cancerous disease, and the vaccine itself. This method involves first using one or more antibodies that are specifically effective against one or more antigens specially expressed by the tumor cells to select one or more mimotopes of said antigens from a phage peptide library. To obtain the vaccine, said mimotopes are conjugated to a macromolecular carrier singly or multiply in the form of their mono-, di-, tri- or oligomers. When administered, the inventively produced vaccine leads to a humoral immune response and thus to the formation of an active immunity as a consequence of vaccination.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: January 23, 2007
    Inventors: Christoph Zielinski, Otto Scheiner, Erika Jensen-Jarolim, Heimo Breiteneder, Hubert Penamberger
  • Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
    Publication number: 20050100551
    Abstract: The present invention provides a method for producing a vaccine against cancerous disease, and the vaccine itself. This method involves first using one or more antibodies that are specifically effective against one or more antigens specially expressed by the tumor cells to select one or more mimotopes of said antigens from a phage peptide library. To obtain the vaccine, said mimotopes are conjugated to a macromolecular carrier singly or multiply in the form of their mono-, di-, tri- or oligomers. When administered, the inventively produced vaccine leads to a humoral immune response and thus to the formation of an active immunity as a consequence of vaccination.
    Type: Application
    Filed: April 12, 2001
    Publication date: May 12, 2005
    Inventors: Christoph Zielinski, Otto Scheiner, Erika Jensen-Jarolim, Heimo Breiteneder, Hubert Penamberger